Resveratrol and its oligomers : modulation of sphingolipid metabolism and signaling in disease

Lim, Keng Gat and Gray, Alexander I. and Anthony, Nahoum G. and MacKay, Simon P. and Pyne, Susan and Pyne, Nigel J. (2014) Resveratrol and its oligomers : modulation of sphingolipid metabolism and signaling in disease. Archives of Toxicology, 88 (12). pp. 2213-2232. ISSN 0340-5761

[img]
Preview
PDF (Final_Resveratrol_and_sphingolipids_in_disease_3_)
Final_Resveratrol_and_sphingolipids_in_disease_3_.pdf
Accepted Author Manuscript

Download (1MB)| Preview

    Abstract

    Resveratrol, a natural compound endowed with multiple health-promoting effects, has received much attention given its potential for the treatment of cardiovascular, inflammatory, neurodegenerative, metabolic and age-related diseases. However, the translational potential of resveratrol has been limited by its specificity, poor bioavailability and uncertain toxicity. In recent years, there has been an accumulation of evidence demonstrating that resveratrol modulates sphingolipid metabolism. Moreover, resveratrol forms higher order oligomers that exhibit better selectivity and potency in modulating sphingolipid metabolism. This review evaluates the evidence supporting the modulation of sphingolipid metabolism and signaling as a mechanism of action underlying the therapeutic efficacy of resveratrol and oligomers in diseases, such as cancer.